# Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery

> **NCT04807621** · PHASE2 · UNKNOWN · sponsor: **Sahlgrenska University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **BIOLOGICAL:** Platelet transfusion
- **BIOLOGICAL:** Fibrinogen concentrate

## Key facts

- **NCT ID:** NCT04807621
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-14
- **Primary completion:** 2022-01
- **Final completion:** 2022-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04807621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04807621, "Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04807621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*